In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Alzamend Neuro Inc’s stock clocked out at $2.24, up 4.67% from its previous closing price of $2.14. In other words, the price has increased by $4.67 from its previous closing price. On the day, 94415.0 shares were traded. ALZN stock price reached its highest trading level at $2.35 during the session, while it also had its lowest trading level at $2.1.
Ratios:
To gain a deeper understanding of ALZN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.03 and its Current Ratio is at 6.03. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Ascendiant Capital Markets on October 01, 2021, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 23 ’25 when McGrath Lynne Fahey sold 30 shares for $2.29 per share. The transaction valued at 69 led to the insider holds 25 shares of the business.
AULT MILTON C III sold 101,394 shares of ALZN for $247,158 on Oct 08 ’25. The Director now owns 28,657 shares after completing the transaction at $2.44 per share. On Oct 09 ’25, another insider, AULT MILTON C III, who serves as the Director of the company, sold 20,397 shares for $2.32 each. As a result, the insider received 47,390 and left with 8,260 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALZN now has a Market Capitalization of 8515593 and an Enterprise Value of 1412416.
Stock Price History:
The Beta on a monthly basis for ALZN is -0.25, which has changed by -0.817094 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, ALZN has reached a high of $12.10, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is -5.30%, while the 200-Day Moving Average is calculated to be -46.48%.
Shares Statistics:
It appears that ALZN traded 125.81K shares on average per day over the past three months and 142050 shares per day over the past ten days. A total of 3.14M shares are outstanding, with a floating share count of 3.04M. Insiders hold about 3.24% of the company’s shares, while institutions hold 4.70% stake in the company. Shares short for ALZN as of 1763078400 were 196244 with a Short Ratio of 1.56, compared to 1760486400 on 104714. Therefore, it implies a Short% of Shares Outstanding of 196244 and a Short% of Float of 6.909999999999999.
Earnings Estimates
The dynamic stock of Alzamend Neuro Inc (ALZN) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$2.06, with high estimates of -$0.8 and low estimates of -$3.32.
Analysts are recommending an EPS of between -$3.55 and -$6.96 for the fiscal current year, implying an average EPS of -$5.26. EPS for the following year is -$3.19, with 2.0 analysts recommending between -$3.01 and -$3.37.
